Brentuximab induced CD 30 + cutaneous lymphoma responded to anti‐ PD 1 treatment

Autor:	Theodoros Iliakis, Alexandros Stratigos, L. Marinos, Afroditi Economidi, P. Panayiotidis, Dimitrios Rigopoulos, V. Nikolaou
Rok vydání:	2019
Předmět:	CD30 business.industry T cell Dermatology medicine.disease Cutaneous lymphoma Lymphoma Infectious Diseases medicine.anatomical_structure medicine Cancer research Cutaneous metabolism Brentuximab vedotin Anti pd1 business medicine.drug
Zdroj:	Journal of the European Academy of Dermatology and Venereology. 33
ISSN:	1468-3083 0926-9959
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9a9411b4a98d7d4ded94f81496c9fdcb https://doi.org/10.1111/jdv.15378 Zobrazit plný text záznamu Plný text